Laidlaw Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Laidlaw Wealth Management’s Portfolio LCTX Stock Details LCTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$264K	Sell
2021 Q2	$353K	Buy
2021 Q1	$272K	Sell
2020 Q4	$300K	Buy
2020 Q3	$124K	Buy
2020 Q2	$104K	Buy
2020 Q1	$89K	Buy
2019 Q4	$27K	Buy